103 related articles for article (PubMed ID: 3674897)
1. [Phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Group].
Nakatsu T; Takahashi H; Furue H
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3114-8. PubMed ID: 3674897
[TBL] [Abstract][Full Text] [Related]
2. [A phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with breast cancer--multi-center cooperative study--Cooperative Study Group of 590-S in Breast Cancer].
Taguchi T; Terasawa T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):467-71. PubMed ID: 3813575
[TBL] [Abstract][Full Text] [Related]
3. [Cooperative phase II study of spansule tegafur (SF-SP)].
Taguchi T
Gan To Kagaku Ryoho; 1984 Feb; 11(2):319-26. PubMed ID: 6421250
[TBL] [Abstract][Full Text] [Related]
4. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
Taguchi T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
[TBL] [Abstract][Full Text] [Related]
5. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].
Taguchi T; Wakui A; Nabeya K; Kurihara M; Isono K; Kakegawa T; Ota K
Gan To Kagaku Ryoho; 1992 Apr; 19(4):483-8. PubMed ID: 1558398
[TBL] [Abstract][Full Text] [Related]
6. [Clinical results of treatment with the UFT fine granule preparation under cooperative study. Tokyo Cancer Chemotherapy Cooperative Study Group].
Futatsuki K; Komita T; Kamano T; Watanabe H
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1274-80. PubMed ID: 3107478
[TBL] [Abstract][Full Text] [Related]
7. [Phase II study of a new fluorinated pyrimidine, ethyl (+/-)-t-6-butoxy-5-fluoro-2, 4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278)].
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1821-6. PubMed ID: 7184376
[TBL] [Abstract][Full Text] [Related]
8. [Joint clinical Phase II study of SF-SP].
Sato T; Sato H; Hanatani Y
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1210-7. PubMed ID: 6428321
[TBL] [Abstract][Full Text] [Related]
9. [Cooperative phase II study of releasing tegafur (SF-SP) against advanced digestive cancers].
Ibayashi J
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1414-9. PubMed ID: 6430244
[TBL] [Abstract][Full Text] [Related]
10. [Phase II study of sustained released granules of tegafur (SF-SP) on inoperable or recurrent gastric cancer].
Sakata Y; Yoshida Y
Gan To Kagaku Ryoho; 1985 May; 12(5):1068-72. PubMed ID: 3922308
[TBL] [Abstract][Full Text] [Related]
11. [Biochemical modulation of 5-FU--effect of low dose CDDP].
Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
[TBL] [Abstract][Full Text] [Related]
12. [Phase II study of FF-705 by Clinical Cooperative Study Group].
Gan To Kagaku Ryoho; 1984 Jan; 11(1):150-6. PubMed ID: 6230055
[TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy of continuous infusion 5-fluorouracil and daily low-dose cisplatin in advanced gastrointestinal and lung adenocarcinoma].
Sasaki K; Hirata K; Denno R; Oikawa I; Mukaiya M; Hiraike N; Yagihashi A; Takasaka H; Katsuramaki T; Yamashiro K; Yamamitsu S; Shirasaka T
Gan To Kagaku Ryoho; 1997 Jun; 24(8):959-64. PubMed ID: 9212804
[TBL] [Abstract][Full Text] [Related]
14. [Phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in gastrointestinal cancer].
Takenaka K; Tamada R; Hiramoto Y; Inokuchi K; Saku M; Oka N; Kano T; Noda S; Nagasaki S; Toda T
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2155-60. PubMed ID: 4062315
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
Hirata K; Horikoshi N; Aiba K; Okazaki M; Denno R; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Shirasaka T
Clin Cancer Res; 1999 Aug; 5(8):2000-5. PubMed ID: 10473078
[TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with upper gastrointestinal carcinomas.
Ajani JA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
[TBL] [Abstract][Full Text] [Related]
17. [A cooperative late phase II trial of l-leucovorin and 5-fluorouracil in the treatment of advanced gastric cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
Takeda S; Taguchi T; Ohta J; Kurihara M; Abe T; Ohtani T; Yonemura Y; Ohno T; Hirabayashi N; Nakano S
Gan To Kagaku Ryoho; 1995 Jun; 22(7):903-10. PubMed ID: 7793996
[TBL] [Abstract][Full Text] [Related]
18. [Phase II study of THP patients with gastrointestinal cancer].
Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hada Y; Hosoma S; Hatayama T; Ogawa Y; Iwamori S; Nagata N
Gan To Kagaku Ryoho; 1986 Feb; 13(2):362-7. PubMed ID: 3947111
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
[TBL] [Abstract][Full Text] [Related]
20. [Clinical efficacy of cis-diamminedichloroplatinum [II] and 5-fluorouracil (UFT) in advanced cancer of the alimentary tract].
Hashimoto T; Omura K; Ishida F; Watanabe Y
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1333-8. PubMed ID: 8346932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
